Status:

UNKNOWN

Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector

Lead Sponsor:

MicroPort CRM

Conditions:

Ventricular Arrythmia

Lead

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary objective of this study is to assess the safety and key electrical performance of the INVICTA leads equipped with DF4 connector: ACTIVE fixation type models (single and dual coil: INVICTA ...

Detailed Description

FRIENDS study is a pre-market approval (INVICTA leads - devices under investigation - are not CE marked), interventional, prospective, longitudinal, international (European), multicenter, single arm s...

Eligibility Criteria

Inclusion

  • Any patient presenting an ICD or CRT-D indication as detailed in the latest European Society of Cardiology (ESC) guidelines
  • Scheduled for a primary implant of an ICD / CRT-D, manufactured by MicroPort CRM and equipped with a RV DF4 connector
  • Signed and dated informed consent

Exclusion

  • Tricuspid valvular disease or tricuspid replacement heart valve (mechanical or tissue)
  • Transient tachyarrhythmias due to reversible causes (such as drug intoxication, electrolyte imbalance, sepsis, hypoxia or other factors as myocardial infarction or electric shock)
  • Contraindication to a maximum single dose of 330 µg dexamethasone sodium phosphate (DSP)
  • Active myocarditis
  • Already included in another clinical study that could confound the results of this study
  • Inability to understand the purpose of the study or to meet follow-up visits at the implanting centre as defined in the investigational plan
  • Patient less than 18 years old or under guardianship or kept in detention
  • Known pregnancy, women in breastfeeding or in childbearing age without an adequate contraceptive method
  • Drug addiction or abuse

Key Trial Info

Start Date :

December 27 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2021

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT03766919

Start Date

December 27 2018

End Date

March 1 2021

Last Update

April 16 2019

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

CHU

Brest, France, 29200

2

CHU

Clermont-Ferrand, France, 63003

3

CH de Valence

Valence, France, 26000

4

Cliniche Humanitas Gavazzeni

Bergamo, Italy, 24125

Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector | DecenTrialz